Clinical Infectious Diseases · 2022 · 50 citations · 12 references
Life SciencesInfectious DiseasesPharmacotherapyInfectious Disease PharmacotherapyMolecular VirologyVirologyAntiviral Drug ResistanceAntiviral ResistanceAntiviral TherapyViral InfectionsViral MutationViral PersistenceAntiviral Resistance MutationsCombination TherapyDrug Combination TherapySars-cov-2 Antiviral ResistanceSars-cov-2 Antiviral TherapySars-cov-2 InfectionSevere Acute Respiratory SyndromeTreatment Of Coronavirus Infections
Viral evolution was evaluated in 47 immunocompromised patients treated with sotrovimab. Sequencing of SARS-CoV-2 following therapy was successful in 16. Mutations associated with sotrovimab resistance were documented in 6; viral replication continued after 30 days in 5. Combination antibody therapy may be required to avoid acquired resistance in immunocompromised patients.
12
Antibody evasion properties of SARS-CoV-2 Omicron sublineages
Sho Iketani, Lihong Liu, Yicheng Guo et al. · Nature · 2022 · 857 citations · Full text
Jeroen J. A. van Kampen, David van de Vijver, Pieter L. A. Fraaij et al. · Nature Communications · 2021 · 843 citations · Full text
SARS-CoV-2 Variants in Patients with Immunosuppression
Lawrence Corey, Chris Beyrer, Myron S. Cohen et al. · New England Journal of Medicine · 2021 · 474 citations · Full text